7210 Wareham Drive, Tampa, FL 33647
January 4, 2024 The history of weight loss drugs in the U.S. is filled with meds that were taken off the market due to nasty side effects, going back to the phen/fen crisis of 1997. Many more followed (Belviq, Qsymia, Taranabant, Acomplia) . These side effects did not emerge until years after entering the market […]
Semaglutide Boom – The Beginning of a Decline? New FDA Report Read More »
Dec. 14, 2023 Medifast on Wednesday marked its first entry into the medically supported weight loss market through a collaboration with LifeMD Inc., a provider of virtual primary care. This venture brings together Optavia’s personalized, coach-guided approach with medical expertise from board-certified LifeMD clinicians and access to weight loss medications, including GLP-1s. Medifast has committed
Medifast Enters Medical Weight Loss Market Read More »
November 2, 2023 WW reported results for its 3rd quarter. Management reported that: “We have successfully returned WeightWatchers to subscriber growth, with Q3 end of period subscribers up 6% year-over-year to 4.0 million. This is a significant achievement and a direct result of our work in reinvigorating our core product,” said Sima Sistani, the company’s
Weight Watchers Reports 3rd Quarter Results Read More »
Dec. 30, 2021 2021 was a historic year for obesity treatment. In June, the Food and Drug Administration approved the weight loss drug semaglutide, which some experts described as a “game changer”. The medication, initially developed to treat Type 2 diabetes, was the first drug treatment to be approved by the FDA for weight management since 2014. Wegovy,
Semaglutide a Game Changer Drug? Read More »